Correlation Between GOLDMAN SACHS and NeuPath Health

Can any of the company-specific risk be diversified away by investing in both GOLDMAN SACHS and NeuPath Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GOLDMAN SACHS and NeuPath Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GOLDMAN SACHS CDR and NeuPath Health, you can compare the effects of market volatilities on GOLDMAN SACHS and NeuPath Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GOLDMAN SACHS with a short position of NeuPath Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of GOLDMAN SACHS and NeuPath Health.

Diversification Opportunities for GOLDMAN SACHS and NeuPath Health

0.63

Correlation Coefficient

GOLDMAN SACHS  NeuPath Health

Poor diversification

The 3 months correlation between GOLDMAN and NeuPath is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding GOLDMAN SACHS CDR and NeuPath Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuPath Health and GOLDMAN SACHS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GOLDMAN SACHS CDR are associated (or correlated) with NeuPath Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuPath Health has no effect on the direction of GOLDMAN SACHS i.e., GOLDMAN SACHS and NeuPath Health go up and down completely randomly.

Pair Corralation between GOLDMAN SACHS and NeuPath Health

Assuming the 90 days trading horizon GOLDMAN SACHS is expected to generate 305.6 times less return on investment than NeuPath Health. But when comparing it to its historical volatility, GOLDMAN SACHS CDR is 1.88 times less risky than NeuPath Health. It trades about 0.0 of its potential returns per unit of risk. NeuPath Health is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  19.00  in NeuPath Health on December 21, 2024 and sell it today you would earn a total of  1.00  from holding NeuPath Health or generate 5.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

GOLDMAN SACHS CDR  vs.  NeuPath Health

GOLDMAN SACHS CDR

Risk-Adjusted Performance

Very Weak

Over the last 90 days GOLDMAN SACHS CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, GOLDMAN SACHS is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

NeuPath Health

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuPath Health may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with GOLDMAN SACHS and NeuPath Health

The main advantage of trading using opposite GOLDMAN SACHS and NeuPath Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GOLDMAN SACHS position performs unexpectedly, NeuPath Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuPath Health will offset losses from the drop in NeuPath Health's long position.

The idea behind GOLDMAN SACHS CDR and NeuPath Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.